Promonitor Quick

A point-of-care test (starting from whole blood or serum) that allows clinicians to detect infliximab and anti-infliximab antibodies in a quick and fully decentralized mode, facilitating immediate decisions.


Personalized Medicine

The tool to facilitate immediate decisions.

  • Promonitor Quick is a set of rapid immunochromatography tests that allow the clinician to measure drug levels and anti-drug antibody levels in a quick and fully decentralized way

Easy to Use

Easy protocol with minimal steps.

  • 4 simple steps
  • Results in 20 minutes
  • Fully decentralized, real point-of-care (POC)
  • Starting from whole blood


Ready for the new emerging market players.

  • Promonitor Quick kits are able to quantify the reference infliximab and the following biosimilars and the corresponding anti-infliximab antibodies: CT-P13, SB2, and GP1111


Reliable and accurate detection in either venous, serum, or capillary circulation (fingerstick).

  • Results show an almost perfect match between specimens and the reference ELISA technique


Intravenous and subcutaneous treatments.

  • Promonitor Quick IFX allows quantification of a broad range of concentrations, facilitating monitoring of intravenous and subcutaneous treatments